Related references
Note: Only part of the references are listed.Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M. Aapro et al.
ANNALS OF ONCOLOGY (2008)
Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study
Carla Ripamonti et al.
SUPPORTIVE CARE IN CANCER (2007)
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma
Robert A. Kyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients - May 2006
Richard Weitzman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients
Jean-Jacques Body et al.
EUROPEAN JOURNAL OF CANCER (2007)
Systematic review: Bisphosphonates and osteonecrosis of the jaws
Sook-Bin Woo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors
A Badros et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Managing the care of patients with bisphosponate-associated osteonecrosis - An American Academy of Oral Medicine position paper
CA Migliorati et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2005)
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
A Bamias et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment
RE Marx et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)
Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone - An emerging oral complication of supportive cancer therapy
CA Migliorati et al.
CANCER (2005)
Special precautions
MVB Nelson
BRITISH DENTAL JOURNAL (2005)
Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: A randomized, placebo-controlled trial
N Kohno et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
F Saad et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma - A randomized, double-blind, multicenter, comparative trial
LS Rosen et al.
CANCER (2003)
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
JJ Body et al.
ANNALS OF ONCOLOGY (2003)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
RE Marx
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma
A Lipton et al.
CANCER (2003)
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
LS Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Bisphosphonate therapy in multiple myeloma: past, present, future
E Jantunen
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma
JR Berenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The role of disodium pamidronate in the management of bone pain due to malignancy
L Groff et al.
PALLIATIVE MEDICINE (2001)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
BE Hillner et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
